Gainers
- Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced a deal to acquire the company for $10.50 per share in cash.
- Sono Group N.V. (NASDAQ:SEV) climbed 65.2% to close at $7.60.
- Sharps Technology, Inc. (NASDAQ:STSS) shares gained 40.5% to close at $2.43 after dipping 18% on Monday. The company recently priced its IPO at $4.25 per share.
- ToughBuilt Industries, Inc. (NASDAQ:TBLT) gained 37% to close at $0.2010 as the company posted a narrower FY21 loss.
- Baosheng Media Group Holdings Limited (NASDAQ:BAOS) rose 33.3% to close at $0.78.
- Terran Orbital Corporation (NYSE:LLAP) gained 28.4% to settle at $4.98.
- MedAvail Holdings, Inc. (NASDAQ:MDVL) jumped 26.4% to close at $2.73.
- Axsome Therapeutics, Inc. (NASDAQ:AXSM) climbed 25.1% to close at $40.92 after the company announced it received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the NDA for its AXS-05.
- Charge Enterprises, Inc. (NASDAQ:CRGE) jumped 24.1% to close at $7.93.
- Zymergen Inc. (NASDAQ:ZY) gained 22.6% to close at $2.01.
- Super Micro Computer, Inc. (NASDAQ:SMCI) gained 22% to close at $44.65 after the company raised its Q3 guidance above analyst estimates.
- Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) rose 21.9% to close at $1.45. Clarus Therapeutics reported presentation of new data for its JATENZO at Androgen Society Annual Meeting Apr. 23 at 10:15 a.m. EDT.
- Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) gained 20.9% to settle at $1.33 after the company announced results from its OTC draft label comprehension study for STENDRA.
- Sunshine Biopharma, Inc. (NASDAQ:SBFM) rose 18.5% to close at $4.10.
- AIM ImmunoTech Inc. (NYSE:AIM) surged 15.5% to close at $1.12. AIM ImmunoTech recently announced the presentation of positive data from a Phase 1 study of Ampligen in metastatic triple-negative breast cancer.
- Leap Therapeutics, Inc. (NASDAQ:LPTX) gained 15.4% to settle at $1.65.
- Tricida, Inc. (NASDAQ:TCDA) rose 15.4% to close at $11.75.
- Candel Therapeutics, Inc. (NASDAQ:CADL) climbed 15% to close at $5.51.
- ThredUp Inc. (NASDAQ:TDUP) jumped 14.4% to close at $8.81.
- Silvergate Capital Corporation (NYSE:SI) climbed 13.2% to settle at $131.67 after the company reported better-than-expected Q1 EPS results.
- Evoke Pharma, Inc. (NASDAQ:EVOK) gained 13.2% to close at $0.4245. Evoke Pharma reported approval of its GIMOTI to Texas Medicaid Preferred Drug List.
- American Campus Communities, Inc. (NYSE:ACC) climbed 12.5% to close at $64.80 after the company announced Blackstone Core+ Perpetual Capital Vehicles will acquire the company for $65.47 per share in cash.
- Gogoro Inc. (NASDAQ:GGR) rose 11.8% to close at $8.94. Gogoro’s Chief Executive Officer Horace Luke said that the company has an adequate amount of chips to meet its needs, Reuters reported.
- Navidea Biopharmaceuticals, Inc. (NASDAQ:NAVB) gained 11.7% to close at $0.99 after the company announced the regulatory approval of Lymphoaim by the Central Drugs Standard Control Organisation in India.
- Annexon, Inc. (NASDAQ:ANNX) gained 11.4% to close at $2.35. Annexon CEO Douglas Love reported the purchase of 60,000 shares at an average price of $2.45 per share.
- Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) gained 9.2% to close at $3.20.
- Party City Holdco Inc. (NYSE:PRTY) rose 8.1% to close at $3.86.
- WeWork Inc. (NYSE:WE) gained 8.1% to close at $6.41 after Piper Sandler initiated coverage on the stock with an Overweight rating and announced a $10 price target.
- Pulse Biosciences, Inc. (NASDAQ:PLSE) gained 7.3% to close at $3.38.
- Sentage Holdings Inc. (NASDAQ:SNTG) rose 6.7% to close at $0.80.
- Sidus Space, Inc. (NASDAQ:SIDU) rose 6.5% to close at $2.97 following a 7% decline on Monday. Sidus Space recently appointed Teresa Burchfield as its Chief Financial Officer.
- Zendesk, Inc. (NYSE:ZEN) rose 6.1% to close at $129.12 after Bloomberg late Monday reported the company is working with Qatalyst on a potential sale.
